Page last updated: 2024-08-21

medroxyprogesterone and HIV Coinfection

medroxyprogesterone has been researched along with HIV Coinfection in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johnson, EL; Kaplan, PW1
Chen, PL; Chipato, T; Doncel, GF; Fichorova, RN; Kwok, C; Mauck, C; Mendonca, K; Morrison, CS; Salata, R1
Bostrom, BA1
Brind, J; Condly, SJ; Kimball, J; Morse, AR; Mosher, SW1
Jones, LB; Morrison, CS; Turner, AN1
Delany, S; Dinat, N; Kleinschmidt, I; McIntyre, JA; Nkala, B; Rees, H; Smith, D1

Reviews

3 review(s) available for medroxyprogesterone and HIV Coinfection

ArticleYear
Caring for transgender patients with epilepsy.
    Epilepsia, 2017, Volume: 58, Issue:10

    Topics: Androgens; Anti-HIV Agents; Anticonvulsants; Antidepressive Agents; Anxiety Disorders; Comorbidity; Depressive Disorder; Drug Interactions; Epilepsy; Estradiol; Estrogens; Health Services for Transgender Persons; HIV Infections; Humans; Medroxyprogesterone; Mineralocorticoid Receptor Antagonists; Progestins; Social Stigma; Spironolactone; Testosterone; Transgender Persons; Transsexualism

2017
Risk of HIV Infection in Depot-Medroxyprogesterone Acetate (DMPA) Users: A Systematic Review and Meta-analysis.
    Issues in law & medicine, 2015,Autumn, Volume: 30, Issue:2

    Topics: Contraceptives, Oral, Synthetic; Female; HIV Infections; Humans; Male; Medroxyprogesterone

2015
Highly effective contraception and acquisition of HIV and other sexually transmitted infections.
    Best practice & research. Clinical obstetrics & gynaecology, 2009, Volume: 23, Issue:2

    Topics: Chlamydia Infections; Contraception; Contraception Behavior; Contraceptives, Oral, Combined; Female; Gonorrhea; Health Knowledge, Attitudes, Practice; HIV Infections; HIV-1; Humans; Intrauterine Devices; Medroxyprogesterone; Prospective Studies; Sexually Transmitted Diseases

2009

Other Studies

3 other study(ies) available for medroxyprogesterone and HIV Coinfection

ArticleYear
The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.
    mBio, 2015, Sep-01, Volume: 6, Issue:5

    Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Disease Susceptibility; HIV Infections; Humans; Immunologic Factors; Immunomodulation; Medroxyprogesterone; Reproductive Tract Infections; Uganda; Young Adult; Zimbabwe

2015
Preface.
    Issues in law & medicine, 2015,Autumn, Volume: 30, Issue:2

    Topics: Abortion, Induced; Contraceptives, Oral, Synthetic; Domestic Violence; Female; HIV Infections; Humans; Medroxyprogesterone; Periodicals as Topic; Pregnancy

2015
Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort.
    Contraception, 2007, Volume: 75, Issue:6

    Topics: Adolescent; Adult; Cohort Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Family Planning Services; Female; HIV Infections; Humans; Incidence; Medroxyprogesterone; Norethindrone; Prevalence; South Africa

2007